Protocol summary

Study aim
Comparison of the efficacy of oral Acetaminophen and oral Ibuprofen for treatment of preterm with patent ductus arteriosus
Design
A clinical trial with parallel groups, single-blinded, randomized (permuted block randomization), phase 3 on 60 newborns, using www.sealedenvelope.com for randomization
Settings and conduct
This interventional study will be conducted from April to Nov 2020. A total of 60 preterm neonates with diagnosis of PDA admitted in NICU of Akbar Abadi Hospital Tehran were selected. Neonates are randomly assigned to two groups. In the first intervention group, oral Acetaminophen is given every 8 hours at a dose of 15 mg/kg for 3 days. In the second intervention group, oral Ibuprofen every 8 hours at a dose of 10 mg/kg for 3 days.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Parent's consent to participate in the study, Gestational age 26 to 37 weeks, Diagnosis of ductus arteriosus based on echocardiographic evidence at 24 to 72 hours after birth. Exclusion criteria: Premature newborn with fever and seizure, Life-threatening infections, Clinical or radiographic evidence of necrotizing enterocolitis Evidence of bleeding, Platelets less than 50,000 per ml Liver failure , Congenital brain-neurological disorders, Metabolic and genetic syndromes, Pulmonary hypoplasia syndrome, Congenital heart anomalies or other fatal abnormalities
Intervention groups
Total of 30 neonates in the first intervention group and 30 neonates in the second intervention group. In the first intervention group, oral Acetaminophen is taken every 8 hours at a dose of 15 mg/kg for 3 days. In the second intervention group, oral Ibuprofen is taken every 8 hours at a dose of 10 mg/kg for 3 days.
Main outcome variables
The closure of the ductus arteriosus (complete, incomplete, unchanged)

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20211010052715N1
Registration date: 2021-11-25, 1400/09/04
Registration timing: retrospective

Last update: 2021-11-25, 1400/09/04
Update count: 0
Registration date
2021-11-25, 1400/09/04
Registrant information
Name
Zahra Hadadi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 2304 6253
Email address
hadadi.za@iums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-04-21, 1400/02/01
Expected recruitment end date
2021-11-06, 1400/08/15
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of the efficacy of oral Acetaminophen and oral Ibuprofen for treatment of preterm with patent ductus arteriosus
Public title
Comparison of the efficacy of oral Acetaminophen and oral Ibuprofen for treatment of preterm with patent ductus arteriosus
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Parent's consent to participate in the study Gestational age 26 to 37 weeks Diagnosis of ductus arteriosus based on echocardiographic evidence at 24 to 72 hours after birth
Exclusion criteria:
Premature newborn with fever and seizure Life-threatening infections, Clinical or radiographic evidence of necrotizing enterocolitis Evidence of bleeding Platelets less than 50,000 per ml Liver failure Congenital brain-neurological disorders, Metabolic and genetic syndromes Pulmonary hypoplasia syndrome Congenital heart anomalies or other fatal abnormalities
Age
From 1 day old to 3 days old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
In this study, the block randomization method is used with blocks of sizes 4 , 6 and 8. The website https://www.sealedenvelope.com is used to create a randomization list. The blocks are randomly selected using this website and given to a researcher who is not involved in choosing the type of drug. Each random chain generated contains a unique code for concealment. The drug regimen is placed in envelopes according to random chains, and after sealing it on the envelopes, the specific number created by the site is written and the envelopes are randomly placed in a box. a box.
Blinding (investigator's opinion)
Single blinded
Blinding description
This study is single-blinded and patients are unaware of the type of medication received. How to blind patients: Acetaminophen and Ibuprofen are both taken orally and given to infants 1-3 days old with a dropper.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Iran University of Medical Sciences
Street address
Iran University of Medical Sciences, Hemat highway next to the Milad tower.
City
Tehran
Province
Tehran
Postal code
۱۴۴۹۶۱۴۵۳۵
Approval date
2021-04-12, 1400/01/23
Ethics committee reference number
IR.IUMS.FMD.REC.1400.050

Health conditions studied

1

Description of health condition studied
Patent ductus arteriosus (PDA)
ICD-10 code
Q25.0
ICD-10 code description
Patent ductus arteriosus

Primary outcomes

1

Description
PDA size
Timepoint
Before and after the intervention
Method of measurement
Echocardiography by pediatiric's cardiologist .

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: Includes premature neonates with PDA diagnosis by pediatric cardiologist. In this group, samples (n=30) received oral Acetaminophen at a dose of 15mg / kg every 8 hours for 3 days.
Category
Treatment - Drugs

2

Description
Intervention group: Includes premature neonates with PDA diagnosis by pediatric cardiologist. In this group, samples (n=30) received oral Ibuprofen at a dose of 10mg / kg every 8 hours for 3 days.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Akbar Abadi Hospital
Full name of responsible person
Zahra Hadadi
Street address
Molavi St, Molavi (cross)
City
Tehran
Province
Tehran
Postal code
۱۱۶۸۷۴۳۵۱۴
Phone
+98 21 5560 6034
Email
hadadi.za@iums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Hosein Keivani
Street address
Shahid Hemmat Highway next to the Milad tower, Iran University of Medical Sciences
City
Tehran
Province
Tehran
Postal code
۱۴۴۹۶۱۴۵۳۵
Phone
+98 21 86701
Email
keivani.h@iums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Iran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Zahra Hadadi
Position
Specialty
Latest degree
Specialist
Other areas of specialty/work
Pediatrics
Street address
No 193, Aliasghar Children's Hospital, Zfar st, Moda
City
Tehran
Province
Tehran
Postal code
1919816766
Phone
+98 21 2304 6253
Fax
Email
hadadi.za@iums.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Semira Mehralizadeh
Position
Assistant Professor
Latest degree
Subspecialist
Other areas of specialty/work
Pediatrics
Street address
No. 193, Vahid dastgerdy Ave, Modares highway, Aliasghar Children Hospital
City
Tehran
Province
Tehran
Postal code
1919816766
Phone
+98 21 2304 6387
Email
mehralizadehmd@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Semira Mehralizadeh
Position
Assistant Professor
Latest degree
Subspecialist
Other areas of specialty/work
Pediatrics
Street address
No. 193, Vahid dastgerdy Ave, Modares highway, Aliasghar Children Hospital
City
Tehran
Province
Tehran
Postal code
1919816766
Phone
+98 21 2304 6387
Email
mehralizadehmd@yahoo.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Not applicable
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Not applicable
Data Dictionary
Not applicable
Loading...